Correlation Between Inovio Pharmaceuticals and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Puma Biotechnology, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Puma Biotechnology.
Diversification Opportunities for Inovio Pharmaceuticals and Puma Biotechnology
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inovio and Puma is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Inovio Pharmaceuticals and Puma Biotechnology
Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the Puma Biotechnology. In addition to that, Inovio Pharmaceuticals is 1.18 times more volatile than Puma Biotechnology. It trades about -0.02 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.0 per unit of volatility. If you would invest 389.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (101.00) from holding Puma Biotechnology or give up 25.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inovio Pharmaceuticals vs. Puma Biotechnology
Performance |
| Timeline |
| Inovio Pharmaceuticals |
| Puma Biotechnology |
Inovio Pharmaceuticals and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inovio Pharmaceuticals and Puma Biotechnology
The main advantage of trading using opposite Inovio Pharmaceuticals and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Inovio Pharmaceuticals vs. Puma Biotechnology | Inovio Pharmaceuticals vs. Iovance Biotherapeutics | Inovio Pharmaceuticals vs. Day One Biopharmaceuticals | Inovio Pharmaceuticals vs. Inozyme Pharma |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |